SBS-101

N/A

Report date: 2022/11/25 17:17:13
NME

Base Information

Drug NameSBS-101
Drug Alias NameSBS-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrnithine decarboxylase inhibitors
TargetsOrnithine decarboxylase
Therapy Area/IndicationsLeukoplakia, Oral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSkyline Biosciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSkyline Biosciences Llc
Active IndicationsN/A
Inactive IndicationsLeukoplakia, Oral

Other Information

ATC CodeN/A
Related LinksN/A